CABOTEGRAVIR

CABOTEGRAVIR was reported 8201 times

CABOTEGRAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROCTITIS GONOCOCCAL 3 0.3000
1 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 254 0.2906
2 ANAL GONOCOCCAL INFECTION 1 0.2500
3 OROPHARYNGEAL GONOCOCCAL INFECTION 6 0.2222
4 BLOOD HIV RNA BELOW ASSAY LIMIT 3 0.2000
5 CONGENITAL CYTOMEGALOVIRUS INFECTION 28 0.1647
6 CD8 LYMPHOCYTE PERCENTAGE INCREASED 1 0.1429
7 HIV TEST FALSE POSITIVE 5 0.1282
8 SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED 11 0.1222
9 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 26 0.1176
10 VIRAL LOAD INCREASED 434 0.1117
11 BIOPSY SITE COMPLICATION 1 0.1000
12 VIRAL LOAD ABNORMAL 17 0.0971
13 CD4 LYMPHOCYTE PERCENTAGE DECREASED 4 0.0909
14 BLOOD CATECHOLAMINES ABNORMAL 2 0.0909
15 BLOOD HIV RNA INCREASED 161 0.0887
16 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 24 0.0863
17 INJECTION SITE MUSCLE ATROPHY 2 0.0625
18 HIV INFECTION 172 0.0570
19 VIROLOGIC FAILURE 270 0.0502
20 CRYPTOSPORIDIOSIS INFECTION 26 0.0495
21 BILE ACIDS ABNORMAL 1 0.0455
22 VIRAL MUTATION IDENTIFIED 165 0.0448
23 PRODUCT ADMINISTERED BY WRONG PERSON 16 0.0419
24 INJECTED LIMB MOBILITY DECREASED 5 0.0350
25 ABDOMINAL LYMPHADENOPATHY 26 0.0300
26 ALLERGIC PHARYNGITIS 1 0.0294
27 HIV VIRAEMIA 6 0.0286
28 PATHOGEN RESISTANCE 251 0.0275
29 ACUTE HEPATITIS B 9 0.0271
30 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 1 0.0270
31 GONORRHOEA 7 0.0259
32 CD4 LYMPHOCYTES INCREASED 6 0.0258
33 ADMINISTRATION SITE NECROSIS 1 0.0250
34 SYPHILIS 17 0.0234
35 ADRENAL GLAND INJURY 1 0.0227
36 ANAL CANCER STAGE III 1 0.0227
37 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 15 0.0226
38 ADMINISTRATION SITE INDURATION 2 0.0222
39 VIRAEMIA 29 0.0209
40 VIRAL LOAD DECREASED 3 0.0205
41 SECONDARY SYPHILIS 2 0.0202
42 NASAL VESTIBULITIS 2 0.0200
43 INJECTION SITE PLAQUE 4 0.0190
44 TOXIC NEUROPATHY 7 0.0178
45 VERTICAL INFECTION TRANSMISSION 2 0.0177
46 CHLAMYDIA TEST POSITIVE 2 0.0177
47 VIRAL LOAD 3 0.0173
48 SUBSTANCE USE 27 0.0173
49 INJECTION SITE FIBROSIS 2 0.0171
50 INJECTION SITE NODULE 188 0.0171
51 INJECTION SITE GRANULOMA 4 0.0169
52 LARYNGEAL NEOPLASM 2 0.0164
53 ACUTE HIV INFECTION 4 0.0162
54 INJECTION SITE ABSCESS 39 0.0157
55 CD4 LYMPHOCYTES DECREASED 33 0.0154
56 ASTHENOSPERMIA 1 0.0154
57 QUARANTINE 3 0.0146
58 MONKEYPOX 4 0.0145
59 CSF HIV ESCAPE SYNDROME 2 0.0145
60 BACTERIAL FOOD POISONING 1 0.0141
61 ALCOHOLIC SEIZURE 1 0.0135
62 ADMINISTRATION SITE WARMTH 1 0.0122
63 COUGH VARIANT ASTHMA 1 0.0119
64 ADMINISTRATION SITE OEDEMA 1 0.0116
65 INJECTION SITE DISCHARGE 62 0.0115
66 DRUG RESISTANCE MUTATION 2 0.0112
67 ADMINISTRATION SITE DISCOMFORT 2 0.0106
68 PHANTOM LIMB SYNDROME 2 0.0106
69 INJECTION SITE PUSTULE 4 0.0105
70 CRYPTOGENIC CIRRHOSIS 1 0.0103
71 INJECTION SITE CYST 3 0.0102
72 ADRENALECTOMY 1 0.0102
73 BACTERIAL PROSTATITIS 1 0.0101
74 HERPES SIMPLEX TEST POSITIVE 2 0.0101
75 DRUG MONITORING PROCEDURE NOT PERFORMED 18 0.0100
76 ENCAPSULATION REACTION 1 0.0097
77 PAPILLOMA 3 0.0095
78 PRODUCT COMPLAINT 240 0.0095
79 HEPATITIS B REACTIVATION 30 0.0094
80 ANGIOMYOLIPOMA 2 0.0093
81 CHLAMYDIAL INFECTION 7 0.0093
82 INJECTION RELATED REACTION 15 0.0091
83 DECORTICATE POSTURE 1 0.0089
84 PHARYNGOTONSILLITIS 2 0.0089
85 DECEREBRATION 1 0.0088
86 MALABSORPTION FROM ADMINISTRATION SITE 2 0.0086
87 LOCAL REACTION 6 0.0081
88 BED BUG INFESTATION 1 0.0079
89 VIRAL RASH 3 0.0074
90 HEPATITIS A 6 0.0071
91 HEPATITIS B SURFACE ANTIBODY POSITIVE 2 0.0068
92 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 123 0.0067
93 NODULE 85 0.0065
94 ABSCESS SOFT TISSUE 1 0.0065
95 MALABSORPTION FROM INJECTION SITE 2 0.0065
96 OCCUPATIONAL EXPOSURE TO PRODUCT 41 0.0064
97 INJECTION SITE DISCOMFORT 65 0.0062
98 CYCLOTHYMIC DISORDER 1 0.0061
99 DOSING ERROR 1 0.0060
100 MUSCLE HYPERTROPHY 2 0.0057
101 STAB WOUND 2 0.0056
102 INDURATION 10 0.0056
103 CATHETER REMOVAL 2 0.0056
104 ACUTE HEPATITIS C 1 0.0055
105 MYOSCLEROSIS 2 0.0054
106 INJECTION SITE CELLULITIS 10 0.0054
107 EXPOSURE TO COMMUNICABLE DISEASE 4 0.0053
108 HEPATITIS B CORE ANTIBODY POSITIVE 2 0.0053
109 INJECTION SITE OEDEMA 9 0.0052
110 INJECTION SITE SCAB 5 0.0052
111 INJECTION SITE INDENTATION 11 0.0051
112 PRODUCT PREPARATION ISSUE 33 0.0050
113 CD8 LYMPHOCYTES DECREASED 1 0.0050
114 INJECTION SITE INFECTION 16 0.0049
115 CORONAVIRUS TEST POSITIVE 5 0.0049
116 LABELLED DRUG-DRUG INTERACTION ISSUE 7 0.0048
117 FAT TISSUE INCREASED 7 0.0048
118 SEXUALLY TRANSMITTED DISEASE 2 0.0046
119 HIV TEST POSITIVE 3 0.0045
120 BREAST ATROPHY 1 0.0045
121 INJECTION SITE NECROSIS 9 0.0044
122 T-LYMPHOCYTE COUNT DECREASED 3 0.0044
123 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
124 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 36 0.0041
125 ANORECTAL INFECTION 1 0.0040
126 PRODUCT DOSE OMISSION ISSUE 1128 0.0038
127 HEPATITIS B 23 0.0038
128 MANUFACTURING PRODUCT SHIPPING ISSUE 2 0.0037
129 ANTICIPATORY ANXIETY 1 0.0037
130 MORNING SICKNESS 2 0.0037
131 INJECTION SITE ATROPHY 6 0.0036
132 SCIATIC NERVE INJURY 3 0.0036
133 INJECTION SITE INDURATION 46 0.0035
134 ANTICOAGULANT THERAPY 1 0.0035
135 WRONG PRODUCT ADMINISTERED 22 0.0033
136 SITTING DISABILITY 2 0.0032
137 DEPRESSIVE SYMPTOM 11 0.0031
138 COLORECTAL ADENOMA 1 0.0031
139 CELLULITIS STAPHYLOCOCCAL 2 0.0031
140 INJECTION SITE PAIN 943 0.0031
141 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 143 0.0031
142 WRONG DEVICE USED 2 0.0030
143 INJECTION SITE INFLAMMATION 15 0.0030
144 MALARIA 2 0.0028
145 ALCOHOL INTOLERANCE 2 0.0028
146 INJECTION SITE HYPOAESTHESIA 4 0.0028
147 ESCHAR 2 0.0027
148 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 46 0.0027
149 INJECTION SITE MASS 96 0.0026
150 EXPOSURE DURING PREGNANCY 161 0.0026
151 CARDIOVASCULAR SYMPTOM 1 0.0026
152 MYCOPLASMA INFECTION 2 0.0026
153 HAEMATOMA MUSCLE 3 0.0025
154 BALANOPOSTHITIS 2 0.0024
155 PRODUCT ADMINISTRATION ERROR 49 0.0024
156 ENZYME LEVEL INCREASED 2 0.0024
157 CARBON MONOXIDE POISONING 1 0.0023
158 PROSTATITIS 7 0.0023
159 INTERCEPTED PRODUCT PRESCRIBING ERROR 3 0.0023
160 SKIN MASS 15 0.0022
161 PARVOVIRUS B19 INFECTION 2 0.0022
162 DISCHARGE 3 0.0022
163 BODY MASS INDEX DECREASED 1 0.0022
164 SKIN GRAFT 2 0.0022
165 ADRENAL NEOPLASM 1 0.0021
166 NEONATAL RESPIRATORY DISTRESS 2 0.0021
167 PRODUCT STORAGE ERROR 185 0.0021
168 INJECTION SITE SCAR 6 0.0021
169 LIPOATROPHY 2 0.0021
170 WRONG SCHEDULE 2 0.0021
171 ECZEMA NUMMULAR 1 0.0020
172 MICTURITION DISORDER 7 0.0020
173 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
174 SCIATICA 32 0.0020
175 HYPOGONADISM 2 0.0020
176 INJECTION SITE SWELLING 150 0.0020
177 SELF-INJURIOUS IDEATION 8 0.0019
178 BODY FAT DISORDER 1 0.0018
179 INJECTION SITE WARMTH 38 0.0018
180 EPIGLOTTITIS 1 0.0018
181 ACARODERMATITIS 2 0.0018
182 PILOERECTION 2 0.0018
183 PNEUMONIA STREPTOCOCCAL 2 0.0018
184 IMMEDIATE POST-INJECTION REACTION 2 0.0018
185 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
186 METABOLIC SURGERY 2 0.0018
187 INJECTION SITE REACTION 121 0.0018
188 ADMINISTRATION SITE PAIN 2 0.0017
189 DYSMETRIA 1 0.0017
190 PRODUCT DISPENSING ERROR 36 0.0017
191 BLADDER DISCOMFORT 2 0.0016
192 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
193 SEROMA 2 0.0016
194 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
195 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
196 INTERCEPTED PRODUCT SELECTION ERROR 2 0.0015
197 ABSCESS 24 0.0015
198 VULVOVAGINAL CANDIDIASIS 2 0.0015
199 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 257 0.0014
200 POOR QUALITY PRODUCT ADMINISTERED 15 0.0014
201 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
202 FOETAL DISTRESS SYNDROME 3 0.0014
203 PRODUCT PREPARATION ERROR 29 0.0014
204 BORDERLINE PERSONALITY DISORDER 1 0.0014
205 ABSCESS LIMB 6 0.0014
206 GAIT INABILITY 47 0.0014
207 APPENDICECTOMY 5 0.0014
208 DENTAL RESTORATION FAILURE 1 0.0014
209 MAJOR DEPRESSION 10 0.0014
210 BIPOLAR I DISORDER 3 0.0014
211 GENERALISED ANXIETY DISORDER 2 0.0014
212 PNEUMONIA PNEUMOCOCCAL 2 0.0013
213 PELVIC INFLAMMATORY DISEASE 2 0.0013
214 BRAIN STEM SYNDROME 1 0.0013
215 SUPERINFECTION 2 0.0013
216 ORAL MUCOSAL EXFOLIATION 2 0.0013
217 INJECTION SITE PARAESTHESIA 2 0.0013
218 ORAL MUCOSAL ERUPTION 2 0.0013
219 MEAN CELL VOLUME DECREASED 2 0.0013
220 INTERCEPTED MEDICATION ERROR 6 0.0013
221 DRUG LEVEL DECREASED 13 0.0013
222 AORTIC DISORDER 1 0.0013
223 DYSBIOSIS 1 0.0012
224 INFLUENZA LIKE ILLNESS 100 0.0012
225 LIVER FUNCTION TEST INCREASED 26 0.0012
226 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0012
227 ARTHROPOD STING 2 0.0012
228 OFF LABEL USE 1050 0.0012
229 PRODUCT DISTRIBUTION ISSUE 11 0.0012
230 PSYCHOTIC DISORDER 35 0.0012
231 MYCOBACTERIAL INFECTION 2 0.0012
232 INJECTION SITE VESICLES 7 0.0012
233 AXONAL NEUROPATHY 1 0.0011
234 PREGNANCY ON ORAL CONTRACEPTIVE 3 0.0011
235 ANOGENITAL WARTS 1 0.0011
236 INTERCEPTED PRODUCT STORAGE ERROR 4 0.0011
237 DRUG DETOXIFICATION 1 0.0011
238 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
239 TREATMENT NONCOMPLIANCE 60 0.0011
240 ESSENTIAL HYPERTENSION 2 0.0011
241 MUSCULOSKELETAL PAIN 57 0.0011
242 LIVE BIRTH 9 0.0011
243 TREATMENT FAILURE 89 0.0011
244 EXPOSURE VIA SKIN CONTACT 27 0.0010
245 BONE SWELLING 1 0.0010
246 ANAL CANCER 1 0.0010
247 MUSCLE RUPTURE 4 0.0010
248 GENE MUTATION 2 0.0010
249 LIPIDS INCREASED 2 0.0010
250 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
251 BUTTERFLY RASH 1 0.0010
252 ECTOPIC PREGNANCY 3 0.0010
253 CHEST INJURY 2 0.0010
254 SKIN INDURATION 2 0.0010
255 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
256 CARPAL TUNNEL DECOMPRESSION 1 0.0009
257 LIPODYSTROPHY ACQUIRED 2 0.0009
258 CERVICAL DYSPLASIA 2 0.0009
259 LIMB MASS 2 0.0009
260 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
261 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
262 TONGUE BLISTERING 2 0.0009
263 INJECTION SITE HAEMATOMA 13 0.0009
264 INJECTION SITE EXTRAVASATION 11 0.0009
265 CRYPTORCHISM 1 0.0009
266 INJECTION SITE PAPULE 4 0.0009
267 TACHYPHRENIA 3 0.0009
268 MASS 12 0.0009
269 SINUS PAIN 2 0.0009
270 PAPULE 6 0.0009
271 NIGHT SWEATS 27 0.0008
272 COLON OPERATION 1 0.0008
273 PULSE ABNORMAL 2 0.0008
274 BLEEDING TIME PROLONGED 1 0.0008
275 FOETAL GROWTH RESTRICTION 5 0.0008
276 DERMAL CYST 2 0.0008
277 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 27 0.0008
278 CARDIOTOXICITY 7 0.0008
279 ENDOCRINE DISORDER 1 0.0008
280 ERECTILE DYSFUNCTION 20 0.0008
281 CALCIUM DEFICIENCY 1 0.0008
282 LIPOMA 2 0.0008
283 TENDERNESS 8 0.0008
284 RESPIRATORY ACIDOSIS 3 0.0008
285 PYREXIA 259 0.0007
286 FOOD POISONING 4 0.0007
287 ALCOHOL POISONING 2 0.0007
288 CLUMSINESS 2 0.0007
289 NONSPECIFIC REACTION 4 0.0007
290 NERVE INJURY 8 0.0007
291 DEATH NEONATAL 1 0.0007
292 HYPERTRANSAMINASAEMIA 5 0.0007
293 SERUM SICKNESS 2 0.0007
294 MUSCLE FATIGUE 3 0.0007
295 CHILLS 83 0.0007
296 CATAPLEXY 1 0.0007
297 DIABETIC FOOT INFECTION 1 0.0007
298 MYALGIA 120 0.0007
299 PRESYNCOPE 17 0.0007
300 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
301 SKIN WARM 4 0.0007
302 DEPRESSION 156 0.0007
303 NEGATIVE THOUGHTS 2 0.0007
304 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
305 PRODUCT COMMUNICATION ISSUE 6 0.0007
306 ANKLE OPERATION 1 0.0007
307 PAIN 414 0.0007
308 RHINITIS ALLERGIC 3 0.0007
309 CHOLANGIOCARCINOMA 1 0.0007
310 PERIPHERAL COLDNESS 9 0.0007
311 DYSCHEZIA 2 0.0007
312 INJECTION SITE ERYTHEMA 81 0.0007
313 MULTIPLE-DRUG RESISTANCE 2 0.0006
314 PREGNANCY WITH IMPLANT CONTRACEPTIVE 3 0.0006
315 BLOOD CREATININE DECREASED 2 0.0006
316 ABORTION INDUCED 6 0.0006
317 MULTIPLE INJURIES 4 0.0006
318 EOSINOPHILIC PNEUMONIA 2 0.0006
319 MUSCLE ATROPHY 8 0.0006
320 TESTICULAR PAIN 2 0.0006
321 LOW BIRTH WEIGHT BABY 5 0.0006
322 INJECTION SITE IRRITATION 8 0.0006
323 SUBCUTANEOUS ABSCESS 3 0.0006
324 AGGRESSION 31 0.0006
325 INCORRECT DISPOSAL OF PRODUCT 2 0.0006
326 HERPES SIMPLEX 4 0.0006
327 DENTAL IMPLANTATION 1 0.0006
328 CORONAVIRUS INFECTION 4 0.0006
329 ANXIETY DISORDER 2 0.0006
330 TONGUE ULCERATION 2 0.0006
331 CEREBELLAR INFARCTION 1 0.0006
332 EXPOSURE TO SARS-COV-2 1 0.0006
333 PRODUCT PRESCRIBING ERROR 14 0.0006
334 SKIN HYPERPIGMENTATION 5 0.0006
335 HEPATITIS C 7 0.0006
336 GRANULOMA 2 0.0006
337 POLYMENORRHOEA 2 0.0006
338 ABORTION SPONTANEOUS 23 0.0006
339 EMOTIONAL POVERTY 1 0.0006
340 NEUTROPENIC SEPSIS 4 0.0006
341 PANIC REACTION 4 0.0006
342 OROPHARYNGEAL DISCOMFORT 5 0.0006
343 CONTRAST MEDIA ALLERGY 1 0.0005
344 DRUG RESISTANCE 14 0.0005
345 BODY TEMPERATURE ABNORMAL 1 0.0005
346 FOETAL EXPOSURE DURING PREGNANCY 44 0.0005
347 INJECTION SITE INJURY 3 0.0005
348 NEURALGIA 13 0.0005
349 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
350 SNORING 2 0.0005
351 INCORRECT DOSE ADMINISTERED 120 0.0005
352 DISCOMFORT 32 0.0005
353 THYROID MASS 2 0.0005
354 MOUTH SWELLING 3 0.0005
355 APHTHOUS ULCER 4 0.0005
356 ATROPHY 1 0.0005
357 RHINOVIRUS INFECTION 2 0.0005
358 MOOD ALTERED 14 0.0005
359 PHARYNGEAL SWELLING 5 0.0005
360 AFFECTIVE DISORDER 4 0.0005
361 SKIN ODOUR ABNORMAL 2 0.0005
362 PRODUCT USE COMPLAINT 8 0.0005
363 PRODUCT PRESCRIBING ISSUE 11 0.0005
364 PATENT DUCTUS ARTERIOSUS 2 0.0005
365 INABILITY TO AFFORD MEDICATION 5 0.0005
366 HAEMATOMA 13 0.0005
367 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
368 SKIN PAPILLOMA 2 0.0005
369 TRIGEMINAL NEURALGIA 2 0.0005
370 CARDIAC DISCOMFORT 1 0.0005
371 GAIT DISTURBANCE 95 0.0005
372 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
373 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
374 AORTIC DISSECTION 2 0.0005
375 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
376 HYPERPYREXIA 2 0.0005
377 ABNORMAL DREAMS 13 0.0005
378 PULMONARY TUBERCULOSIS 2 0.0005
379 PROCTALGIA 3 0.0005
380 UNDERDOSE 34 0.0005
381 TENSION HEADACHE 2 0.0005
382 BLOOD TESTOSTERONE INCREASED 1 0.0005
383 BIPOLAR DISORDER 5 0.0005
384 GROIN PAIN 4 0.0005
385 ACCIDENT AT WORK 1 0.0005
386 PRODUCT USE ISSUE 85 0.0005
387 DANDRUFF 1 0.0005
388 INJECTION SITE PRURITUS 30 0.0004
389 BRAIN FOG 7 0.0004
390 CONDITION AGGRAVATED 134 0.0004
391 FEELING HOT 27 0.0004
392 BLOOD TESTOSTERONE DECREASED 3 0.0004
393 DISLOCATION OF VERTEBRA 1 0.0004
394 HAEMOGLOBIN INCREASED 2 0.0004
395 IMMUNE THROMBOCYTOPENIA 2 0.0004
396 MENTAL DISORDER 19 0.0004
397 DEPRESSED MOOD 23 0.0004
398 IRON DEFICIENCY ANAEMIA 4 0.0004
399 HEPATIC STEATOSIS 8 0.0004
400 FEELING OF DESPAIR 2 0.0004
401 FLANK PAIN 4 0.0004
402 LYMPHADENOPATHY 15 0.0004
403 SKIN ABRASION 2 0.0004
404 JOINT STIFFNESS 11 0.0004
405 MOBILITY DECREASED 30 0.0004
406 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
407 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
408 PRODUCT USE IN UNAPPROVED INDICATION 102 0.0004
409 SLEEP DISORDER 29 0.0004
410 VITAMIN D DEFICIENCY 4 0.0004
411 ORAL DISORDER 3 0.0004
412 INCORRECT DOSAGE ADMINISTERED 2 0.0004
413 SCAR 7 0.0004
414 ILLNESS 42 0.0004
415 INTERCEPTED PRODUCT PREPARATION ERROR 5 0.0004
416 DENTAL OPERATION 1 0.0004
417 TRANSAMINASES INCREASED 9 0.0004
418 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
419 NIGHTMARE 14 0.0004
420 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
421 INJECTION SITE DISCOLOURATION 5 0.0004
422 ANAPHYLACTIC REACTION 22 0.0004
423 COLD SWEAT 7 0.0004
424 CELLULITIS 20 0.0004
425 EMPHYSEMA 4 0.0004
426 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
427 APPENDICITIS PERFORATED 1 0.0004
428 INJURY ASSOCIATED WITH DEVICE 8 0.0004
429 INTERCEPTED PRODUCT ADMINISTRATION ERROR 3 0.0004
430 INJECTION SITE RASH 12 0.0004
431 HELICOBACTER INFECTION 4 0.0004
432 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
433 FOETAL DEATH 2 0.0004
434 SKIN NECROSIS 2 0.0004
435 BEDRIDDEN 5 0.0004
436 MOUTH ULCERATION 8 0.0004
437 ILL-DEFINED DISORDER 23 0.0004
438 MOOD SWINGS 12 0.0004
439 BACK PAIN 87 0.0004
440 OVERWEIGHT 2 0.0004
441 MUSCLE DISORDER 3 0.0004
442 MUSCLE TIGHTNESS 6 0.0004
443 EAR CONGESTION 1 0.0004
444 MENSTRUATION DELAYED 4 0.0004
445 SKIN LACERATION 4 0.0004
446 HYPERAESTHESIA 3 0.0004
447 FLUSHING 37 0.0004
448 GASTROINTESTINAL PAIN 4 0.0004
449 SWELLING 34 0.0004
450 MENSTRUAL DISORDER 3 0.0004
451 STEVENS-JOHNSON SYNDROME 8 0.0004
452 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
453 ELECTRIC SHOCK SENSATION 1 0.0004
454 ANGIOPATHY 2 0.0004
455 ENDOTRACHEAL INTUBATION 1 0.0004
456 PRODUCT LEAKAGE 2 0.0004
457 PAIN IN EXTREMITY 105 0.0004
458 SKIN REACTION 5 0.0004
459 RASH PRURITIC 19 0.0004
460 SUICIDAL IDEATION 32 0.0003
461 HERPES VIRUS INFECTION 2 0.0003
462 PARAESTHESIA ORAL 5 0.0003
463 HYPOKINESIA 5 0.0003
464 PRODUCT LABEL CONFUSION 2 0.0003
465 ABORTION 1 0.0003
466 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
467 URTICARIA 57 0.0003
468 DECREASED INTEREST 2 0.0003
469 ENERGY INCREASED 2 0.0003
470 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
471 RASH 147 0.0003
472 FACIAL PAIN 3 0.0003
473 HYPERLIPIDAEMIA 4 0.0003
474 HEAVY MENSTRUAL BLEEDING 3 0.0003
475 THERAPY CESSATION 17 0.0003
476 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67 0.0003
477 LIP SWELLING 11 0.0003
478 EMBOLISM VENOUS 1 0.0003
479 TYPE 2 DIABETES MELLITUS 11 0.0003
480 DYSAESTHESIA 1 0.0003
481 CHEST X-RAY ABNORMAL 1 0.0003
482 POOR QUALITY SLEEP 7 0.0003
483 PIGMENTATION DISORDER 2 0.0003
484 BRAIN DEATH 1 0.0003
485 LYMPHOMA 5 0.0003
486 ADVERSE DRUG REACTION 29 0.0003
487 ACCIDENTAL EXPOSURE TO PRODUCT 33 0.0003
488 SYNCOPE 32 0.0003
489 NASAL DRYNESS 2 0.0003
490 SWELLING OF EYELID 2 0.0003
491 ANXIETY 88 0.0003
492 SARS-COV-2 TEST POSITIVE 4 0.0003
493 LETHARGY 17 0.0003
494 RHINORRHOEA 19 0.0003
495 INFARCTION 2 0.0003
496 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
497 WEIGHT DECREASED 81 0.0003
498 JOINT EFFUSION 2 0.0003
499 BLOOD CREATININE ABNORMAL 1 0.0003
500 DEPRESSION SUICIDAL 1 0.0003
501 UNINTENDED PREGNANCY 3 0.0003
502 DEFAECATION URGENCY 2 0.0003
503 BURNING SENSATION 20 0.0003
504 EAR PRURITUS 1 0.0003
505 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
506 CONJUNCTIVAL HYPERAEMIA 1 0.0003
507 SUICIDE ATTEMPT 17 0.0003
508 MOVEMENT DISORDER 9 0.0003
509 HYPERHIDROSIS 36 0.0003
510 ARTHRALGIA 115 0.0003
511 TONGUE DISORDER 2 0.0003
512 APATHY 4 0.0003
513 CUTANEOUS VASCULITIS 1 0.0003
514 TOOTH FRACTURE 3 0.0003
515 PSYCHIATRIC SYMPTOM 2 0.0003
516 AMYLASE INCREASED 1 0.0003
517 EXPIRED PRODUCT ADMINISTERED 9 0.0003
518 RASH PAPULAR 6 0.0003
519 OCULAR DISCOMFORT 3 0.0003
520 PAROSMIA 2 0.0003
521 CHEMOTHERAPY 1 0.0003
522 HEPATIC ENZYME INCREASED 18 0.0003
523 BOWEL MOVEMENT IRREGULARITY 2 0.0003
524 LIMB DISCOMFORT 8 0.0003
525 SWOLLEN TONGUE 8 0.0003
526 MUSCLE SPASMS 47 0.0003
527 HEADACHE 160 0.0003
528 MULTIPLE ALLERGIES 2 0.0003
529 FURUNCLE 2 0.0003
530 NEUROPATHY PERIPHERAL 24 0.0003
531 EXPOSURE VIA BREAST MILK 1 0.0003
532 OBESITY 4 0.0003
533 ATRIAL FLUTTER 2 0.0003
534 WOUND 7 0.0003
535 BLEPHARITIS 1 0.0002
536 FATIGUE 194 0.0002
537 OROPHARYNGEAL PAIN 23 0.0002
538 SENSORY LOSS 2 0.0002
539 PARAESTHESIA 39 0.0002
540 HYPERSENSITIVITY 46 0.0002
541 ENURESIS 1 0.0002
542 FRUSTRATION TOLERANCE DECREASED 2 0.0002
543 HYPOAESTHESIA 37 0.0002
544 INTENTIONAL DOSE OMISSION 7 0.0002
545 BODY TEMPERATURE INCREASED 5 0.0002
546 HYPERSOMNIA 7 0.0002
547 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
548 ABNORMAL FAECES 2 0.0002
549 ARTHRITIS BACTERIAL 1 0.0002
550 SPINAL OPERATION 3 0.0002
551 ANAPHYLACTOID REACTION 1 0.0002
552 PHOTOSENSITIVITY REACTION 4 0.0002
553 WEIGHT INCREASED 54 0.0002
554 DERMATITIS ALLERGIC 3 0.0002
555 INJECTION SITE HAEMORRHAGE 19 0.0002
556 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
557 MUSCULOSKELETAL DISCOMFORT 4 0.0002
558 OCULAR HYPERAEMIA 11 0.0002
559 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
560 MUSCULOSKELETAL STIFFNESS 20 0.0002
561 ABDOMINAL ABSCESS 1 0.0002
562 PURPURA 2 0.0002
563 BLOOD CREATINE INCREASED 1 0.0002
564 NERVOUS SYSTEM DISORDER 7 0.0002
565 ERYTHEMA 46 0.0002
566 HAEMOLYTIC ANAEMIA 2 0.0002
567 GASTROENTERITIS VIRAL 4 0.0002
568 CHROMATURIA 5 0.0002
569 NEPHROLITHIASIS 10 0.0002
570 RESPIRATORY DISTRESS 6 0.0002
571 MALAISE 95 0.0002
572 ARTHRITIS INFECTIVE 1 0.0002
573 HUNGER 3 0.0002
574 PERSONALITY CHANGE 2 0.0002
575 EYE SWELLING 8 0.0002
576 CHEST DISCOMFORT 22 0.0002
577 DIARRHOEA HAEMORRHAGIC 2 0.0002
578 SPINAL DISORDER 2 0.0002
579 SPUTUM DISCOLOURED 2 0.0002
580 BRONCHOSPASM 3 0.0002
581 PARALYSIS 3 0.0002
582 ANGINA PECTORIS 6 0.0002
583 RASH ERYTHEMATOUS 10 0.0002
584 ANGER 7 0.0002
585 SINUS BRADYCARDIA 2 0.0002
586 ORAL HERPES 4 0.0002
587 ANGIOEDEMA 9 0.0002
588 BREATH SOUNDS ABNORMAL 1 0.0002
589 INSOMNIA 54 0.0002
590 HOSPICE CARE 2 0.0002
591 MUSCULAR WEAKNESS 23 0.0002
592 HYPOTONIA 2 0.0002
593 SALIVARY HYPERSECRETION 2 0.0002
594 SWELLING FACE 13 0.0002
595 COVID-19 35 0.0002
596 BRAIN INJURY 2 0.0002
597 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
598 ERYSIPELAS 1 0.0002
599 TOXIC SKIN ERUPTION 2 0.0002
600 EXTRA DOSE ADMINISTERED 8 0.0002
601 PRURITUS 75 0.0002
602 ENDOCARDITIS 1 0.0002
603 INITIAL INSOMNIA 2 0.0002
604 CACHEXIA 1 0.0002
605 MUSCULOSKELETAL CHEST PAIN 3 0.0002
606 TEMPERATURE INTOLERANCE 2 0.0002
607 SKIN ULCER 5 0.0002
608 EYE DISCHARGE 2 0.0002
609 PANIC ATTACK 7 0.0002
610 WEIGHT FLUCTUATION 2 0.0002
611 DIZZINESS 95 0.0002
612 SCRATCH 2 0.0002
613 RENAL PAIN 2 0.0002
614 PREMATURE DELIVERY 3 0.0002
615 IMPAIRED WORK ABILITY 4 0.0002
616 ANAL FISSURE 1 0.0002
617 CHEILITIS 1 0.0002
618 BACK DISORDER 3 0.0002
619 OEDEMA 10 0.0002
620 PALLOR 5 0.0002
621 MANIA 3 0.0002
622 SKIN LESION 5 0.0002
623 ASTHENOPIA 1 0.0002
624 STAPHYLOCOCCAL INFECTION 6 0.0002
625 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
626 RASH MACULO-PAPULAR 4 0.0002
627 DRUG INEFFECTIVE 236 0.0002
628 THROAT IRRITATION 8 0.0002
629 SKIN INFECTION 2 0.0002
630 CHEST PAIN 33 0.0002
631 PANCREATITIS ACUTE 4 0.0002
632 SKIN EXFOLIATION 15 0.0002
633 DRUG INTERACTION 28 0.0002
634 CHOLECYSTECTOMY 2 0.0002
635 DYSGEUSIA 13 0.0002
636 MYOCARDITIS 2 0.0002
637 SKIN DISCOLOURATION 8 0.0002
638 CORONARY ARTERY BYPASS 1 0.0002
639 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
640 DYSPEPSIA 17 0.0002
641 SYRINGE ISSUE 3 0.0002
642 SPINAL PAIN 2 0.0002
643 SURGERY 10 0.0002
644 NASAL CONGESTION 10 0.0002
645 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
646 ACUTE MYOCARDIAL INFARCTION 5 0.0002
647 HEAD DISCOMFORT 3 0.0002
648 CHOLECYSTITIS 2 0.0002
649 CARDIAC PACEMAKER INSERTION 1 0.0002
650 ROAD TRAFFIC ACCIDENT 7 0.0002
651 GOUT 3 0.0002
652 TOOTHACHE 3 0.0002
653 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
654 HYPERGLYCAEMIA 6 0.0002
655 SCHIZOPHRENIA 2 0.0002
656 END STAGE RENAL DISEASE 3 0.0002
657 DERMATITIS ACNEIFORM 1 0.0002
658 ACCIDENTAL OVERDOSE 6 0.0002
659 ABDOMINAL PAIN 38 0.0002
660 FEELING ABNORMAL 39 0.0002
661 NASOPHARYNGITIS 30 0.0002
662 SMALL INTESTINAL OBSTRUCTION 2 0.0002
663 HYPERCALCAEMIA 2 0.0002
664 MEDICATION ERROR 9 0.0002
665 INFLUENZA 18 0.0002
666 NECK PAIN 9 0.0002
667 MIDDLE INSOMNIA 3 0.0002
668 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
669 HEPATIC CIRRHOSIS 3 0.0002
670 BLEPHAROSPASM 1 0.0002
671 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
672 DIARRHOEA 102 0.0002
673 NAUSEA 125 0.0002
674 PROTEINURIA 3 0.0002
675 TACHYCARDIA 14 0.0002
676 DIABETES MELLITUS 12 0.0002
677 HEPATITIS 4 0.0002
678 PERIPHERAL SWELLING 24 0.0002
679 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
680 ANAPHYLACTIC SHOCK 4 0.0002
681 DIPLOPIA 4 0.0002
682 HAEMORRHOIDS 3 0.0002
683 BONE PAIN 9 0.0002
684 BLOOD CREATININE INCREASED 10 0.0002
685 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
686 PULMONARY CONGESTION 2 0.0002
687 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
688 BLOOD PRESSURE ABNORMAL 3 0.0002
689 APPETITE DISORDER 1 0.0002
690 SKIN DISORDER 5 0.0001
691 HOSPITALISATION 23 0.0001
692 IRRITABILITY 9 0.0001
693 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
694 MENSTRUATION IRREGULAR 4 0.0001
695 JOINT RANGE OF MOTION DECREASED 2 0.0001
696 BREAST MASS 1 0.0001
697 EYE PRURITUS 5 0.0001
698 PRODUCT PHYSICAL ISSUE 3 0.0001
699 STOMATITIS 9 0.0001
700 PRODUCTIVE COUGH 7 0.0001
701 ECCHYMOSIS 1 0.0001
702 RIB FRACTURE 3 0.0001
703 CONTUSION 14 0.0001
704 ENCEPHALITIS 1 0.0001
705 MENTAL STATUS CHANGES 4 0.0001
706 FEELING COLD 4 0.0001
707 RASH MACULAR 5 0.0001
708 RENAL IMPAIRMENT 12 0.0001
709 BLISTER 8 0.0001
710 DYSPNOEA 80 0.0001
711 SEASONAL ALLERGY 2 0.0001
712 JOINT INJURY 3 0.0001
713 INJECTION SITE BRUISING 11 0.0001
714 CRYING 5 0.0001
715 ABDOMINAL DISCOMFORT 23 0.0001
716 DYSSTASIA 4 0.0001
717 PALPITATIONS 16 0.0001
718 DYSURIA 5 0.0001
719 LABORATORY TEST ABNORMAL 4 0.0001
720 CEREBRAL DISORDER 1 0.0001
721 URINARY INCONTINENCE 4 0.0001
722 ARTHROPOD BITE 1 0.0001
723 SOMNOLENCE 27 0.0001
724 SNEEZING 3 0.0001
725 RESPIRATORY DISORDER 4 0.0001
726 DECREASED APPETITE 31 0.0001
727 HOT FLUSH 10 0.0001
728 COUGH 37 0.0001
729 BLOOD PRESSURE INCREASED 20 0.0001
730 INSURANCE ISSUE 2 0.0001
731 DISSOCIATION 1 0.0001
732 TENDONITIS 2 0.0001
733 CONCUSSION 1 0.0001
734 RENAL DISORDER 6 0.0001
735 DELUSION 2 0.0001
736 MENINGIOMA 2 0.0001
737 HYPERTENSION 27 0.0001
738 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
739 PNEUMOTHORAX 2 0.0001
740 RESPIRATORY TRACT CONGESTION 2 0.0001
741 DIABETIC KETOACIDOSIS 3 0.0001
742 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
743 VOMITING 58 0.0001
744 DEEP VEIN THROMBOSIS 8 0.0001
745 ASTHENIA 46 0.0001
746 INJECTION SITE URTICARIA 3 0.0001
747 HERPES ZOSTER 7 0.0001
748 OSTEONECROSIS 4 0.0001
749 EYE DISORDER 4 0.0001
750 VISUAL IMPAIRMENT 15 0.0001
751 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
752 ACUTE CORONARY SYNDROME 1 0.0001
753 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
754 FUNGAL INFECTION 4 0.0001
755 EOSINOPHIL COUNT INCREASED 1 0.0001
756 ATRIAL SEPTAL DEFECT 1 0.0001
757 DRUG USE DISORDER 1 0.0001
758 ABDOMINAL PAIN LOWER 3 0.0001
759 INFECTION 17 0.0001
760 INFLAMMATION 6 0.0001
761 PARANOIA 2 0.0001
762 DYSPHAGIA 11 0.0001
763 PULMONARY EMBOLISM 11 0.0001
764 CARDIAC MURMUR 1 0.0001
765 ORTHOSTATIC HYPOTENSION 2 0.0001
766 EOSINOPHILIA 2 0.0001
767 GASTRITIS 3 0.0001
768 DRUG ERUPTION 2 0.0001
769 THIRST 2 0.0001
770 GASTROINTESTINAL DISORDER 10 0.0001
771 ANAL INCONTINENCE 1 0.0001
772 BLOOD BILIRUBIN INCREASED 3 0.0001
773 THROAT TIGHTNESS 3 0.0001
774 LEUKOCYTOSIS 2 0.0001
775 OSTEOMYELITIS 2 0.0001
776 LIMB INJURY 3 0.0001
777 PELVIC PAIN 2 0.0001
778 RESTLESSNESS 4 0.0001
779 ADVERSE EVENT 10 0.0001
780 ARTHROPATHY 6 0.0001
781 BLOOD CHOLESTEROL INCREASED 5 0.0001
782 APPENDICITIS 1 0.0001
783 DEFORMITY 1 0.0001
784 EYE PAIN 6 0.0001
785 PHOTOPHOBIA 2 0.0001
786 DYSARTHRIA 4 0.0001
787 FOOT FRACTURE 2 0.0001
788 DISEASE RECURRENCE 5 0.0001
789 FEELING JITTERY 2 0.0001
790 MIGRAINE 10 0.0001
791 POST PROCEDURAL COMPLICATION 2 0.0001
792 LOWER LIMB FRACTURE 2 0.0001
793 LIVER FUNCTION TEST ABNORMAL 3 0.0001
794 DIZZINESS POSTURAL 1 0.0001
795 OESOPHAGEAL CARCINOMA 3 0.0001
796 SINUS DISORDER 2 0.0001
797 ABNORMAL BEHAVIOUR 4 0.0001
798 HAEMATOCRIT DECREASED 2 0.0001
799 PREMATURE BABY 3 0.0001
800 APHASIA 3 0.0001
801 LACRIMATION INCREASED 3 0.0001
802 FEEDING DISORDER 2 0.0001
803 VERTIGO 6 0.0001
804 THERAPY INTERRUPTED 7 0.0001
805 ALOPECIA 19 0.0001
806 TOOTH LOSS 2 0.0001
807 ABDOMINAL DISTENSION 10 0.0001
808 DRUG-INDUCED LIVER INJURY 3 0.0001
809 DERMATITIS 2 0.0001
810 SEIZURE 11 0.0001
811 DERMATITIS ATOPIC 5 0.0001
812 NO ADVERSE EVENT 17 0.0001
813 LOSS OF CONSCIOUSNESS 12 0.0001
814 DRUG INTOLERANCE 9 0.0001
815 ACNE 7 0.0001
816 DEVICE LEAKAGE 4 0.0001
817 FAECES DISCOLOURED 2 0.0001
818 BACK INJURY 1 0.0001
819 CHOLELITHIASIS 3 0.0001
820 INTENTIONAL PRODUCT MISUSE 8 0.0001
821 HEART RATE INCREASED 9 0.0001
822 HAEMATOCHEZIA 5 0.0001
823 HYPOTENSION 18 0.0001
824 PNEUMONIA 29 0.0001
825 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
826 HEART RATE IRREGULAR 2 0.0001
827 FLATULENCE 5 0.0001
828 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
829 URINARY TRACT INFECTION 15 0.0001
830 DERMATITIS CONTACT 1 0.0001
831 HAEMATURIA 3 0.0001
832 ABDOMINAL PAIN UPPER 18 0.0001
833 TINNITUS 4 0.0001
834 DEVICE USE ERROR 3 0.0001
835 ELECTROLYTE IMBALANCE 1 0.0001
836 CAESAREAN SECTION 1 0.0001
837 BACTERAEMIA 1 0.0001
838 COMPLETED SUICIDE 7 0.0001
839 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
840 BURSITIS 1 0.0001
841 AGITATION 6 0.0001
842 LIVER INJURY 2 0.0001
843 HEPATIC FUNCTION ABNORMAL 3 0.0001
844 DRY EYE 4 0.0001
845 PNEUMONIA ASPIRATION 2 0.0001
846 INTESTINAL OBSTRUCTION 3 0.0001
847 BRAIN OEDEMA 1 0.0001
848 CHRONIC KIDNEY DISEASE 6 0.0001
849 HAEMATEMESIS 2 0.0001
850 CARDIOVASCULAR DISORDER 2 0.0001
851 SINUSITIS 8 0.0001
852 CEREBROVASCULAR ACCIDENT 13 0.0001
853 NERVOUSNESS 4 0.0001
854 DEAFNESS 2 0.0001
855 SPEECH DISORDER 4 0.0001
856 ARTHRITIS 6 0.0001
857 ANKYLOSING SPONDYLITIS 1 0.0001
858 PANCREATITIS 4 0.0001
859 DEVICE DIFFICULT TO USE 5 0.0001
860 ADVERSE REACTION 1 0.0001
861 BLOOD PRESSURE DECREASED 5 0.0001
862 DEHYDRATION 10 0.0001
863 DRY MOUTH 6 0.0001
864 LUNG NEOPLASM MALIGNANT 3 0.0001
865 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
866 POLLAKIURIA 3 0.0001
867 APHONIA 1 0.0001
868 DEMENTIA 2 0.0001
869 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
870 BLINDNESS UNILATERAL 1 0.0001
871 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
872 PAIN IN JAW 2 0.0001
873 CARDIOGENIC SHOCK 1 0.0001
874 EYE IRRITATION 4 0.0001
875 ACCIDENTAL UNDERDOSE 1 0.0001
876 VAGINAL HAEMORRHAGE 3 0.0001
877 FALL 23 0.0001
878 ANOSMIA 1 0.0001
879 SEPTIC SHOCK 3 0.0001
880 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
881 DYSPHONIA 4 0.0001
882 ASCITES 2 0.0001
883 LIVER DISORDER 3 0.0001
884 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
885 DRY SKIN 9 0.0001
886 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
887 HEPATIC FAILURE 2 0.0001
888 JOINT SWELLING 8 0.0001
889 DEATH 57 0.0001
890 VISION BLURRED 9 0.0001
891 EPILEPSY 2 0.0001
892 EMOTIONAL DISORDER 2 0.0001
893 GYNAECOMASTIA 2 0.0001
894 ANKLE FRACTURE 1 0.0001
895 CYANOSIS 1 0.0001
896 HEAD INJURY 2 0.0001
897 SEPSIS 7 0.0001
898 THROMBOCYTOPENIA 7 0.0001
899 BLOOD GLUCOSE DECREASED 3 0.0001
900 ASTHMA 7 0.0001
901 BLOOD POTASSIUM INCREASED 1 0.0001
902 DRUG LEVEL INCREASED 1 0.0001
903 VIRAL INFECTION 2 0.0001
904 COAGULOPATHY 1 0.0001
905 CANDIDA INFECTION 1 0.0001
906 ACUTE KIDNEY INJURY 9 0.0001
907 DEVICE DEFECTIVE 1 0.0001
908 DELIRIUM 2 0.0001
909 MYOCARDIAL INFARCTION 10 0.0001
910 DISTURBANCE IN ATTENTION 3 0.0001
911 BLOOD GLUCOSE ABNORMAL 1 0.0001
912 BRONCHITIS 4 0.0001
913 CONJUNCTIVITIS 1 0.0001
914 BACTERIAL INFECTION 1 0.0001
915 CARDIAC DISORDER 5 0.0001
916 OXYGEN SATURATION DECREASED 3 0.0001
917 DYSPNOEA EXERTIONAL 2 0.0001
918 BLOOD URINE PRESENT 1 0.0001
919 ERUCTATION 1 0.0001
920 EAR PAIN 1 0.0001
921 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
922 CHOKING 1 0.0001
923 MEMORY IMPAIRMENT 7 0.0001
924 WHEEZING 3 0.0001
925 DISABILITY 1 0.0001
926 CATARACT 3 0.0001
927 NEUTROPHIL COUNT DECREASED 2 0.0000
928 TREMOR 8 0.0000
929 RHABDOMYOLYSIS 2 0.0000
930 BLOOD GLUCOSE INCREASED 9 0.0000
931 OSTEOARTHRITIS 2 0.0000
932 INTENTIONAL OVERDOSE 3 0.0000
933 HYPOACUSIS 2 0.0000
934 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
935 AMNESIA 3 0.0000
936 PSORIASIS 6 0.0000
937 CONSTIPATION 10 0.0000
938 NEOPLASM MALIGNANT 3 0.0000
939 THERAPY NON-RESPONDER 2 0.0000
940 SKIN IRRITATION 2 0.0000
941 COGNITIVE DISORDER 2 0.0000
942 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
943 BLOOD PRESSURE FLUCTUATION 1 0.0000
944 HYPOGLYCAEMIA 2 0.0000
945 CEREBRAL INFARCTION 1 0.0000
946 LUNG DISORDER 2 0.0000
947 EPISTAXIS 3 0.0000
948 AGEUSIA 1 0.0000
949 FLUID RETENTION 2 0.0000
950 HAEMOGLOBIN DECREASED 4 0.0000
951 ECZEMA 2 0.0000
952 ANHEDONIA 1 0.0000
953 BRADYCARDIA 2 0.0000
954 CARDIAC FAILURE 3 0.0000
955 OVERDOSE 8 0.0000
956 PANCYTOPENIA 2 0.0000
957 BALANCE DISORDER 3 0.0000
958 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
959 BLOOD POTASSIUM DECREASED 1 0.0000
960 EMOTIONAL DISTRESS 4 0.0000
961 RENAL FAILURE 4 0.0000
962 TOXICITY TO VARIOUS AGENTS 5 0.0000
963 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
964 INJURY 2 0.0000
965 SKIN BURNING SENSATION 2 0.0000
966 C-REACTIVE PROTEIN INCREASED 1 0.0000
967 RHEUMATOID ARTHRITIS 3 0.0000
968 COLITIS 1 0.0000
969 DISORIENTATION 1 0.0000
970 PROSTATE CANCER 2 0.0000
971 THROMBOSIS 2 0.0000
972 OEDEMA PERIPHERAL 3 0.0000
973 CARDIO-RESPIRATORY ARREST 1 0.0000
974 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
975 COLITIS ULCERATIVE 1 0.0000
976 PRODUCT QUALITY ISSUE 3 0.0000
977 ARRHYTHMIA 1 0.0000
978 ANAEMIA 4 0.0000
979 COLORECTAL CANCER 1 0.0000
980 HAEMORRHAGE 2 0.0000
981 PLATELET COUNT DECREASED 2 0.0000
982 CONFUSIONAL STATE 3 0.0000
983 BLADDER CANCER 1 0.0000
984 DISEASE PROGRESSION 2 0.0000
985 DEVICE EXPULSION 1 0.0000
986 NEUTROPENIA 2 0.0000
987 CARDIAC ARREST 1 0.0000
988 DRUG ABUSE 1 0.0000
989 DRUG WITHDRAWAL SYNDROME 1 0.0000
990 ATRIAL FIBRILLATION 1 0.0000